Skip to main content

ProSanos, Windber Research Institute Collaborate to Study Impact of Lifestyle on Disease

NEW YORK, Sept. 24 - ProSanos and the Windber Research Institute have partnered to study the impact of lifestyle changes on patient response to disease, the organizations said today.


ProSanos, based in La Jolla, Calif., will provide bioinformatics for data integration and disease modeling based on biological samples from Windber, Penn.-based Windber Research Institute.


Financial details of the agreement were not disclosed.


The collaboration will initially focus on the treatment of heart disease, according to the organizations.


Click here for more information.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.